ClinicalTrials.gg
Not yet recruitingNCT07773480Updated Aug 19, 2026

Formative Evaluation of a Mobile Application Facilitated Self-directed Rehabilitation Programme for Knee Osteoarthritis

An interventional study of Self-directed rehabiliation using the mobile application in Knee Osteoarthritis, sponsored by Singapore General Hospital. Not yet recruiting at 1 site in Singapore. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Singapore General Hospital · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
45 Years and older
Sex
All
01

Study summary

In Singapore, knee osteoarthritis (OA) is a prevalent musculoskeletal condition, reflecting global trends of an aging population and lifestyle factors. With Singapore's rapidly aging population and the rising prevalence of obesity and sedentary lifestyles, knee OA has become increasingly common. According to recent studies, symptomatic OA of the knee affects around one-fifth (\~300K) of Singaporeans aged 50 years or older. Individuals with advanced knee OA and severe disability often require a total knee replacement (TKR) surgery. While knee replacement surgery is an effective option for severe knee OA, it is costly and there are risks of complications, and should only be considered when all appropriate non-surgical treatment options have been exhausted. Existing research suggests at least a quarter of knee replacements could have been avoided through more optimal conservative treatments.

Despite established healthcare systems and treatment pathways, studies in several settings report that the majority of patients with OA do not receive appropriate and optimal medical care. In Singapore, several factors such as cost, extended wait times, cultural factors and travel inconvenience pose barriers to accessing physiotherapy services. These factors hinder patients' ability to access care resulting in suboptimal care, poor outcomes, and needless economic burden. Thus, there is a large unmet need for innovative and flexible strategies to deliver effective conservative management and treatment for knee OA widely and at a relatively low cost.

Solutions that empower individuals and allow for self-directed rehabilitation without the need for real-time human supervision could be the key to improve effectiveness, accessibility and reduce the reliance on healthcare manpower. Given the prevalence of mobile phone, mobile applications offer a promising avenue for delivering self-directed rehabilitation programs to adults with knee OA. Previous self-directed rehabilitation programs for patients with knee OA have shown promise, however, the adoption and adherence to these programmes remain low, particularly among older adults who may not be technologically savvy. Developing an application that is tailored to the needs and capabilities of older adults with knee osteoarthritis is crucial to improve engagement and long-term adherence to the programme.

The investigators have previously developed a technology-enabled self-directed rehabilitation program for patients who have undergone TKR for primary knee OA. Subsequently, Managing Osteoarthritis of the knee using Therapist-Technology Optimized Rehabilitation (MO-knee-TOR) - a standalone mobile app to facilitate self-directed rehabilitation and complement a "blended" care approach involving an initial face-to-face session with the physiotherapist was developed. MO-knee-TOR was developed for patients with TKR and subsequently evaluated in 2 pilot randomised controlled trials (RCTs). In one of the RCTs, it was found that self-directed rehabilitation post TKR facilitated using the mobile application improved exercise adherence without compromising safety and clinical outcomes. In this current proposal, MO-knee-TOR is adapted for conservative knee OA management through a single-arm pre-post feasibility study with a nested qualitative component.

02

Conditions studied

  • Knee Osteoarthritis
03

In context

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 30 is below the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Singapore General Hospital is the lead sponsor of 270 studies on the registry; 57 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Meet the National Institute for Health and Care Excellence (NICE) osteoarthritis clinical criteria (7)
  • aged 45 years and over
  • activity related knee joint pain
  • morning stiffness ≤30 min
  • History of knee pain on most days for ≥3 months
  • Able to give and to participate fully in the interventions and assessment procedures
  • Has a smartphone and be willing to use it during the study.
  • Able to share photos/ videos with other phone contacts using smartphone

Exclusion criteria

Exclusion Criteria:

  • Patients who meet any of the exclusion criteria mentioned below will be excluded from participation.
  • Rheumatoid arthritis and other systemic arthritis
  • A previous history of stroke and other major neurological conditions
  • An intention to undergo knee joint replacement surgery or have had a knee joint replacement
  • Has significant back or other non-knee pain
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Self-directed rehabilitation using the mobile application

    Participants will be instructed on the installation and use of the mobile application on their personal mobile phones. Participants will then have to perform the assigned tasks using the mobile application for 12 weeks

    Device: Self-directed rehabiliation using the mobile application

Interventions

  • DeviceSelf-directed rehabiliation using the mobile application

    Participants will be instructed on the installation and use of the mobile application on their personal mobile phones during their first outpatient physiotherapy session. Participants will then have to perform the assigned tasks using the mobile application for 12 weeks

06

What researchers measure

Primary outcomes

  1. Feasibility

    The feasibility of evaluating the prototype in a larger trial will be assessed using predefined progression criteria including, including recruitment and retention rates, adherence to the program, incidence of adverse events, and improvement in function. Progression will be guided using thresholds categorized as "proceed," "proceed with protocol amendments," or "significant amendments required" based on the criteria defined for each feasibility domain.

    Time frame: 12 weeks after using the mobile application

Secondary outcomes

  1. Gait speed

    Gait speed will be measured from walking a distance of 4m at comfortable pace and 9m at fast pace with a 2m acceleration and deceleration zone before and after the timed section of 9m.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  2. Knee range-of-motion

    A long-arm goniometer will be used to measure active-assisted knee flexion and extension range-of-motion with the participants in supine position

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  3. Incidental and planned exercise (IPEQ)

    This is a tool developed to measure physical activity, distinguishing between incidental exercise (activities that are not planned but contribute to overall physical activity, like walking to work or taking the stairs) and planned exercise (deliberate, structured exercise like going to the gym or running)

    Time frame: 12 weeks after using the mobile application

  4. Health-related quality of life

    The EQ5D-5L is a standardised instrument to measure health related quality of life in cost-effectiveness analysis

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  5. Muscle strength

    Isotonic quadriceps strength will be determined using the one-repetition maximum test, which is the maximum load the patient could lift once in good form. A submaximal warm-up was provided by instructing the patient to perform bilateral knee extension at \< 10 kgs. The range of-motion for the test was set from 90° to 40° of knee flexion to avoid the increased patellofemoral joint stress associated with terminal knee extension

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  6. Handgrip strength test

    Participants' grip strength will be measured using Jamar hand dynamometer

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  7. Weight bearing symmetry

    This assesses the ability of the participants to weight bear on their limb. With their feet on 2 portable force plates, participants will stand up from a standard chair, and weight-bearing symmetry is calculated by expressing the peak force produced by the operated leg as a percentage of that produced by the unoperated leg.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  8. 5-repetition-sit-to-stand test

    A test to assess participants' ability to rise from a chair and return to the sitting position. The time taken for participant to stan up and sit down five times as fast as posible from standard chair (43-47cm) without the use of their hands will be recorded. This test is a measure that is performed as part of standard clinical practice and is also a measure of lower limb strength and dynamic balance.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  9. Physical function

    Participants will report their physical function using the Short Modified Arthritis Measure for Function (Short-MAC-F), which assesses difficulty in performing common daily activities related to knee function, including stair negotiation, rising from sitting, walking on a flat surface, getting in and out of a car, and dressing. Each item is rated on a 5-point Likert scale, where 0 indicates "none" and 4 indicates "extreme" difficulty. Higher scores indicate greater functional limitation.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  10. Treatment satisfaction

    Participants will rate their satisfaction with the rehabilitation programme using the prototype on a 11 point Likert scale, with 0 indicating "no satisfaction" and 10 indicating "complete satisfaction".

    Time frame: 12 weeks after using the mobile application

  11. Exercise Compliance/Adherence

    Self-reported compliance will be collected by asking participants how many times they completed their exercises. Compliance will also be determined from the data logs captured by the mobile application.

    Time frame: 12 weeks after using the mobile application

  12. Brief Fear of Movement

    Participants will report their fear of movement related to knee osteoarthritis using the Brief Fear of Movement Scale (BFOM). The scale consists of multiple statements assessing beliefs about movement, injury, and pain. Each item is rated on a 4-point Likert scale, where 1 indicates "strongly disagree" and 4 indicates "strongly agree."

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  13. Psychological distress

    Four-dimensional symptom questionnaire (4DSQ) will be used to assess psychological distress, anxiety, depression and

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  14. Perceived Need for Knee Replacement Surgery

    Participants will rate how necessary they perceive knee replacement surgery for their condition based on knee symptoms over the past week using an 11-point numeric rating scale from 0 to 10 (allowing increments of 0.5), where 0 indicates "not at all necessary" and 10 indicates "totally necessary." Participants will also provide a categorical rating of perceived necessity, ranging from "not at all necessary" to "totally necessary." Higher scores indicate a greater perceived need for knee replacement surgery.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  15. Pain

    Participants will rate their knee pain intensity during specific activities using a Visual Analogue Scale (VAS), ranging from 0 to 10, where 0 indicates "no pain" and 11 indicates "worst imaginable pain." Higher scores indicate greater pain intensity.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  16. Participant Experience and Perceptions (Exit Interview)

    Participants will attend an exit interview session at study completion to evaluate their experiences and perceptions of using the mobile application and force platforms for self-directed rehabilitation. Qualitative data will be collected through guided interviews, recorded, and analyzed thematically to assess usability, acceptability, and user experience. Findings from these interviews will be used to inform refinements to optimize the application design and overall user experience.

    Time frame: 12 weeks after using the mobile application

  17. Physical Function

    Participants will provide an overall rating of their knee condition using a global rating scale reflecting their perception of their knee and associated problems. Higher scores indicate greater perceived severity of impairment.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

Other outcomes

  1. Education

    Participants will report their highest level of education attained, categorized into predefined levels (e.g., primary, secondary, tertiary).

    Time frame: Pre-intervention

  2. Race

    Race will be self-reported by participants and categorized into predefined groups (e.g., Chinese, Malay, Indian, Others) based on standard demographic classifications.

    Time frame: Pre-intervention

  3. Co-morbidities

    Co-morbidities will be recorded based on participant self-report and/or medical records, including the presence of chronic conditions such as hypertension, diabetes, cardiovascular disease, and others.

    Time frame: Pre-intervention

  4. Kellgren-Lawrence Grading

    Severity of knee osteoarthritis will be assessed using the Kellgren-Lawrence (K-L) grading scale based on radiographic findings, with grades ranging from 0 (no radiographic features of osteoarthritis) to 4 (severe osteoarthritis).

    Time frame: Pre-intervention

  5. Height

    Height (in centimeters) will be measured or self-reported and used to calculate body mass index (BMI) in kg/m².

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  6. Weight

    Weight (in kilograms) will be measured or self-reported and used to calculate body mass index (BMI) in kg/m².

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  7. Gender

    Gender will be self-reported by participants and categorized as male or female

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  8. Comfort With Technology

    Participants will report their confidence and frequency of using technology in daily life. Confidence in using technology will be assessed using a 4-point scale, where 0 indicates "not at all confident" and 3 indicates "extremely confident," with higher scores indicating greater confidence. Frequency of technology use will be assessed across a range of common digital tools (e.g., mobile phone, SMS, computer, email, tablet, video conferencing platforms, online shopping, internet use, and social media). Each item will be rated on a 6-point scale ranging from "never" to "every day," with higher scores indicating more frequent use of technology.

    Time frame: Pre-intervention;

  9. Knee Osteoarthritis Knowledge Scale

    Knowledge of knee osteoarthritis will be assessed using the Knee Osteoarthritis Knowledge Scale, with higher scores indicating greater understanding of the condition, its management, and treatment options.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

  10. E-Health Literacy

    Participants will rate their agreement with statements assessing their ability to find and use online health information using a 5-point Likert scale, where 1 indicates "strongly disagree" and 5 indicates "strongly agree." Higher scores indicate greater perceived eHealth literacy.

    Time frame: Pre-intervention

  11. Perceived Social Support (Multidimensional Scale of Perceived Social Support - MSPSS, Family Subscale)

    Participants will rate their perceived social support from family using the Multidimensional Scale of Perceived Social Support (MSPSS). Items are rated on a 7-point Likert scale, where 1 indicates "very strongly disagree" and 7 indicates "very strongly agree." The scale assesses perceived emotional and practical support from family, including help with decision-making, availability of support, and ability to discuss problems. Higher scores indicate greater perceived social support.

    Time frame: Pre-intervention; 12 weeks after using the mobile application

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Jun 2027, 10 months later.

Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 10 months is below that.

Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 2, 2026
First posted
Aug 19, 2026
StartEst.
Aug 1, 2026
Primary completionEst.
Jun 1, 2027
CompletionEst.
Dec 31, 2027
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07773480
Responsible party
Sponsor
First posted
Aug 19, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Aug 19, 2026

Study contacts

Ee Lin Woon
Contact
woon.ee.lin@sgh.com.sg
81253463

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion